My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2017
HIVMA Clinical Fellowship Program

Applications are being accepted now for the 2018-2019 HIVMA Clinical Fellowship program. The program supports newly trained physicians with gaining HIV clinical experience working with medically underserved patient populations. With a goal of increasing the number of HIV physicians and strengthening commitments to clinical care for HIV-infected patients in minority communities, HIVMA awards grants to support one-year of HIV clinical training to up to two fellows per year. Grants are made to institutions to support a stipend of $60,000 as well as additional funding to cover fringe benefits for one year, administrative costs and further educational opportunities. The deadline for applications is January 8, 2018. Strong preference will be given to African American and Latino candidates and to applicants pursuing training in the Southeastern U.S. More information is available on the HIVMA website.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

CMS Updates: Diagnostics Reimbursement Cuts, Medicare Physician Fee Schedule, QPP & ID
Federal Funding Update
HHS Tick-borne Disease Working Group
WHO Declares Commitment to End TB by 2030
Science Speaks
HIVMA Medical Students Program
HIVMA Clinical Fellowship Program
Young Investigator Prizes Available for Human Immunology & Vaccine Research
The Year in Review
ID Fellowship Match Results: Interest in ID Holds Steady
Tax Reform Bills Pose Threats to Public Health, Medical Education, Coverage
Journal Club
Invest in Our Path Forward with the IDSA Foundation
Help Us Improve the IDSA and HIVMA Websites!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.